Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$6.26 - $13.31 $730,028 - $1.55 Million
-116,618 Reduced 69.41%
51,400 $0
Q4 2018

Feb 15, 2019

SELL
$5.69 - $11.28 $11,277 - $22,356
-1,982 Reduced 1.17%
168,018 $1.03 Million
Q3 2018

Nov 14, 2018

BUY
$9.69 - $17.79 $1.65 Million - $3.02 Million
170,000 New
170,000 $0

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $28.8M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.